⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

NUVB

Nuvation Bio Inc.

Healthcare · Biotechnology

6.52USD

-0.0900 (-1.36%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 6.52
P/E—
Dvd Ind Yld—
P/B9.14
P/S13.7
Curr EV/T12M EBITDA-15.3
Mkt Cap (USD)2.3B
Curr EV (USD)2.1B
2)

Per Share Data

EPS T12M-107.47
DPS—
Bk Val Per Sh0.73
Rev/Sh487.14
Cash/Sh1.88
Curr Shares Out350.1M
FCF/Sh-321.45
3)

Cash Flow Analysis

P/CF-19.3
Curr P/FCF-20.7
CF/NI0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-70.9%
Eff Interest Rate16.8%
4)

Growth Potential

Dil EPS 1Y Gr71.6%
Cap 1Y Gr-23.7%
BPS 1Y Gr-48.1%
R&D To Sales75.8%
Retention Rate100.0%
Rev 1Y Gr699.0%
FCF 1Y Gr—
Assets 1Y Gr10.0%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-81.0%
Pretax Margin-88.2%
Net Margin-88.2%
ROA-21.5%
ROE-47.8%
ROC-27.4%
Asset Turnover0.24
6)

Structure

Current Ratio8.37
Quick Ratio7.98
Debt/Assets33.4%
Debt/Com Eq97.9%
Net Debt/EBITDA0.07
Tot Debt/Capital49.5%
Gross Margin8.5%
EBIT/Int Exp-5.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.